$AMC Entertainment (AMC.US)$
46,000 options itm. If they are exercised and not yet hedge for, thats 4.6m shares needed. Still looks good

Hello, mooers！
Not too long ago, we released the Institution Tracking feature.
We have gathered many positive comments on our feature from your lively discussions in the first part.
 As @Anonymoosaid: we can see the top AMCs (Asset Management Company) of the United States with their holdings, and their position changes with their total investment funds, Normally it is in trillions.
By observing the position movements of these to...

$Luminar Technologies (LAZR.US)$ announced the upsizing and completion of their convertible notes offering, which they plan to use for an increased share buyback program.
The company, which is developing lidar-based self driving software and sensors, announced the deal for 1.25% convertible notes was fully subscribed including an upsizing for $625M in gross proceeds. Luminar had previously estimated that this would lead to $608M in net proceeds. The company "expects to use over $300 million of the proceeds for $Luminar Technologies (LAZR.US)$ share purchases," having previously announced plans to buy "$250M or more" of shares.
“We have more conviction than ever in our market leadership and business trajectory, and are opportunistically capitalizing on what we believe to be a substantially undervalued and volatile share price,” said Tom Fennimore, Chief Financial Officer of Luminar in the press release.
Beyond the share repurchase plan, the company plans to use the net proceeds to invest in series production capacity expansion, new commercial wins, technology roadmap advancement, international expansion, and accelerating software development, and said it remains on track to enter the series production phase by the end of 2022.
Luminar shares are up 2.8% today amidst a buoyant day for electric vehicle related companies, with $Tesla (TSLA.US)$ up 4.9%, $Nikola (NKLA.US)$ up 16%, and Nio $NIO Inc (NIO.US)$ up 2.1%. The share buyback news comes just over a year after Luminar came public via a SPAC merger, and with shares down nearly 50% for the year. The company has grown revenues this year but has yet to turn a gross profit and has seen widening operating and net losses, a reminder of its early stage nature.

$Keppel (BN4.SG)$ looks like they can't get back to high price again

Currently, Wood and her disruptive vision are facing a huge test. The flagship fund ARK Innovation ETF (ARKK) just had its worst weekly performance since February, falling 12.7% to the lowest level in over a year. Six out of the company's eight strategies recorded declines in 2021, with the worst performing strategy having a decline of 37%. $ARK Genomic Revolution ETF (ARKG.US)$ ARKK opened in the New York market with an initial drop of 4.8% and recovered by the closing, rising 1.5%. The fund has fallen nearly 24% this year.
ARK's actively managed ETFs made a total of 7 transactions on the day, buying 5 stocks and selling 2 stocks.
② $ARK Fintech Innovation ETF (ARKF.US)$ csi commodity equity index $ARK Innovation ETF (ARKK.US)$ Adding to their position $Signify Health (SGFY.US)$ is a leading healthcare platform that utilizes advanced analytics, technology, and a nationwide network of healthcare providers to create and support value-based payment programs.
ARKK position increased $Teladoc Health (TDOC.US)$ Teladoc is a telehealth company that provides on-demand healthcare through mobile devices, the internet, video, and phone. Its solutions connect physicians, healthcare professionals, healthcare providers, and users directly, offering a wide range of acute diagnoses such as upper respiratory infections, urinary tract infections, sinusitis, skin conditions, anxiety, smoking cessation, and more.
Sell ARKK. $Editas Medicine (EDIT.US)$Editas Medicine is a genome editing company. The company treats genetic diseases by correcting pathogenic genes.
Medicine是一家基因组编辑公司。该公司通过修正致病基因治疗遗传疾病。

$BlackBerry (BB.US)$ no eye see

$Asian Pay Tv Tr (S7OU.SG)$ great for regular quarterly dividends. current level at 7% per annum